Announcements Trials

Browse Landscape

Phase

Status

Recruiting 22 Active not recruiting 13 Completed 9 Terminated 3 Withdrawn 1 Not yet recruiting 1 Available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 28 Neoplasms 26 Prostatic Neoplasms 22 Colorectal Neoplasms 17 Head and Neck Neoplasms 14 Pancreatic Neoplasms 11 Lung Neoplasms 10 Brain Neoplasms 10 Neoplasm Metastasis 9 Carcinoma, Renal Cell 9 Squamous Cell Carcinoma of Head and Neck 8 Melanoma 8 Carcinoma, Non-Small-Cell Lung 8 Triple Negative Breast Neoplasms 7 Recurrence 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 7 Lymphoma 7 Glioblastoma 7 Ovarian Neoplasms 6 Lymphoma, Follicular 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 5 Lymphoma, B-Cell 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Kidney Neoplasms 5 Hematologic Neoplasms 5 Sarcoma 4 Liver Neoplasms 4

Interventions

pembrolizumab 1 olaparib 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Liposarcoma × 1 year × Clear all

NCT06116578 2025-12-01

NeoSarc

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Withdrawn

Liposarcoma, Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡